Group 1 - The agricultural chemical sector increased by 1.71% on November 10, with Chengxing Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 4018.6, up 0.53%, while the Shenzhen Component Index closed at 13427.61, up 0.18% [1] - Chengxing Co., Ltd. saw a closing price of 13.13, with a rise of 9.97% and a trading volume of 962,900 shares, amounting to a transaction value of 1.257 billion yuan [1] Group 2 - The agricultural chemical sector experienced a net outflow of 1.192 billion yuan from major funds, while retail investors saw a net inflow of 1.64 billion yuan [2] - The top gainers in the agricultural chemical sector included Hualu Hengsheng, with a closing price of 28.61 and a rise of 7.68%, and Lu Hua Technology, with a closing price of 3.54 and a rise of 7.27% [1] - The sector's overall trading activity reflected significant participation from retail investors, contrasting with the outflow from institutional and speculative funds [2]

Core Points - The Shanghai Composite Index is at 3977.20 points, slightly above the annual line with a change of 0.02% [1] - A total trading volume of A-shares reached 929.27 billion yuan today [1] - 30 A-shares have surpassed the annual line, with notable stocks showing significant deviation rates [1] Summary by Category Stock Performance - Dahua Intelligent (002512) has the highest deviation rate at 9.08%, with a daily increase of 10.04% and a turnover rate of 16.96% [1] - Zhongmin Energy (600163) follows with a deviation rate of 6.19%, increasing by 9.96% today [1] - Fujian Expressway (600033) shows a 4.40% deviation rate with a daily increase of 5.03% [1] Trading Activity - The total trading volume of A-shares today is 929.27 billion yuan, indicating active market participation [1] - Stocks like Chengdu Bank (601838) and Zhejiang Dingli (603338) have lower deviation rates, just above the annual line [1][2] Notable Stocks - Other stocks with significant performance include Maike Audi (300341) with a 3.58% deviation rate and a daily increase of 5.68% [1] - Stocks with minor deviations include Chongqing Water (601158) and Zhejiang Dingli (603338), both showing minimal changes [2]

Core Viewpoint - The growth regulator, brassinosteroid, is gaining traction in the agricultural sector due to national green pesticide policies, with its market size expected to reach 1.5 billion yuan in 2024 and exceed 2 billion yuan by 2030 [1][10]. Industry Overview - Brassinosteroid, with the chemical formula C28H48O6, is a new type of green and environmentally friendly plant growth regulator, widely present in plants and known for its high biological activity [3]. - It promotes the growth of various crops, improves quality, and increases yield, making it popular among farmers, especially in the production of economic crops like fruits, vegetables, and flowers, as well as major crops like rice, wheat, and corn [1][10]. Industry Policies - The market for brassinosteroid is gaining attention due to its high efficiency, broad spectrum, and safety features, which align with the increasing focus on food security and green agriculture policies [5][6]. - Recent policies, such as the implementation of the "14th Five-Year Plan" for agricultural green development, emphasize the safe and efficient application of plant growth regulators [12]. Industry Chain - The brassinosteroid industry chain includes upstream components like steroid compounds and solvents, midstream production, and downstream applications in agriculture, horticulture, and forestry [7]. - The total sown area of crops in China is projected to grow from 165.9 million hectares in 2018 to 173 million hectares in 2024, with a compound annual growth rate of 0.7%, driving the demand for pesticides, including brassinosteroid [7]. Current Industry Status - The pesticide industry in China has developed a complete industrial system, becoming the largest pesticide producer globally. The production of chemical pesticide raw materials is expected to increase significantly due to supportive national policies and product structure optimization [8][9]. - In 2024, the production of chemical pesticide raw materials is projected to reach 3.675 million tons, a year-on-year increase of 37.6% [9]. Competitive Landscape - The brassinosteroid market in China is becoming increasingly competitive, with a growing number of companies entering the sector, including Meibang Co., Ltd. and *ST Huifeng [2][10]. - Companies like Yunnan Yunda Technology Agricultural Chemical Co., Ltd. are focusing on research and development of brassinosteroid products, contributing to the industry's growth [11]. Industry Development Trends - The market for brassinosteroid is expected to expand due to increased support for green agriculture and rising consumer demands for high-quality agricultural products [12]. - The industry is witnessing a trend towards consolidation, with smaller companies facing challenges, while those with advantages in technology and market promotion are likely to thrive [13]. - The development of long-lasting brassinosteroid products is becoming a key focus, supported by advancements in technologies that enhance the effectiveness and duration of these products [14].

证券代码：002496 证券简称：*ST辉丰 公告编号：2025-039 江苏辉丰生物农业股份有限公司 关于子公司破产清算的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、子公司被申请破产清算情况概述 （一）接管债务人的财产、印章和账簿、文书等资料； （二）调查债务人财产状况，制作财产状况报告； 三、对公司的影响 科菲特公司被指定管理人接管后，科菲特公司将不再纳入公司合并报表范围。本次子公 司破产清算对公司损益将产生正面影响，具体财务状况及最终影响以破产清算执行结果和会 计师审计报告为准。 （三）决定债务人的内部管理事务； （四）决定债务人的日常开支和其他必要开支； （五）在第一次债权人会议召开之前，决定继续或者停止债务人营业； （六）管理和处分债务人的财产； （七）代表债务人参加诉讼、仲裁或者其他法律程序； （八）提议召开债权人会议； （九）法律规定的及本院认为管理人应当履行的其他职责。 公司将持续关注该事项的后续进展情况，并按有关规定及时履行信息披露义务，敬请广 大投资者注意投资风险。 四、备查文件 公司子公司江苏科菲特生化技术股份有限公司（以下 ...

Core Viewpoint - *ST Huifeng's subsidiary, Jiangsu Kofit Biochemical Technology Co., Ltd., has been ordered to undergo bankruptcy liquidation by the Yancheng Dafeng District People's Court, which is expected to have a positive impact on the company's financial performance [1] Group 1 - Jiangsu Kofit Biochemical Technology Co., Ltd. received a bankruptcy liquidation decision from the Yancheng Dafeng District People's Court [1] - The company will no longer be included in the consolidated financial statements following the appointment of a manager to oversee the liquidation process [1] - The bankruptcy liquidation is anticipated to positively affect the company's profit and loss, with the final financial impact to be determined by the liquidation execution results and the auditor's report [1]

Group 1 - The average stock price of A-shares is 13.84 yuan, with 26 stocks priced below 2 yuan, the lowest being *ST Gao Hong at 0.38 yuan [1] - Among the low-priced stocks, 9 are ST stocks, accounting for 34.62% of the total [1] - The Shanghai Composite Index closed at 3954.79 points as of October 31 [1] Group 2 - Among the low-priced stocks, 11 increased in price today, with Jin Zheng Da, Rong Sheng Development, and Ya Bo Shares leading with increases of 2.79%, 2.55%, and 2.31% respectively [1] - Conversely, 9 stocks decreased, with *ST Yuan Cheng, Liao Gang Shares, and Shan Ying International showing declines of 4.88%, 4.47%, and 2.21% respectively [1] - The table lists various low-priced stocks along with their latest closing prices, daily price changes, turnover rates, and industry classifications [1][2]

Core Insights - The average stock price of A-shares is 14.06 yuan, with 28 stocks priced below 2 yuan, the lowest being *ST Gao Hong at 0.38 yuan [1][2] - Among the low-priced stocks, 12 are ST stocks, accounting for 42.86% of the total [1] - In terms of market performance, 11 of the low-priced stocks increased in price, with HNA Holding, ST Lingnan, and Jin Zheng Da showing the highest gains of 3.55%, 2.58%, and 1.68% respectively [1] Low-Priced Stocks Overview - The lowest priced stock is *ST Gao Hong at 0.38 yuan, followed by *ST Yuan Cheng at 0.86 yuan and *ST Su Wu at 0.96 yuan [1] - The daily performance of low-priced stocks shows that 11 stocks increased while 11 decreased, with *ST Yuan Cheng, ST Jing Lan, and ST Ming Cheng experiencing the largest declines of 4.44%, 2.25%, and 1.60% respectively [1] - The table of low-priced stocks includes various sectors such as telecommunications, construction decoration, pharmaceuticals, real estate, and steel [1][2]

证券代码：002496 证券简称：*ST辉丰 公告编号：2025-036 江苏辉丰生物农业股份有限公司 关于公司董事、监事、高级管理人员辞职及补选公司非独立董事的公告 本公司及董事会、监事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 江苏辉丰生物农业股份有限公司（以下简称"公司"）董事会于近日收到公司董事、副 总经理、财务负责人周京先生和董事杨进华女士的书面辞职报告。周京先生因个人原因辞去 公司第九届董事、战略委员会委员及副总经理、财务负责人职务；杨进华女士因根据《中国 中化企业领导人员公司外兼职管理细则》的要求辞去公司第九届董事会董事、审计委员会委 员职务。周京先生、杨进华女士辞职后，将不再担任公司其他职务。 公司监事会于近日收到公司监事施伟锋先生的的书面辞职报告。施伟锋先生因公司工作 调整原因辞去公司第九届监事会监事职务。 公司对周京先生、杨进华女士、施伟锋先生在任职期间勤勉尽责，为公司发展作出的贡 献表示衷心感谢！ 公司于 2025 年 10 月 27 日召开第九届董事会第十二次会议，审议通过了《关于补选公 司非独立董事的议案》。因董事周京先生、杨进华女士辞去公司 ...

Financial Performance - The company's operating revenue for the third quarter reached ¥62,102,694.79, representing a year-on-year increase of 42.95%[5] - The net profit attributable to shareholders was -¥14,692,782.66, a decline of 56.08% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥18,339,335.40, a decrease of 53.13% year-on-year[5] - The basic and diluted earnings per share were both -¥0.0097, a decrease of 56.31% compared to the previous year[5] - The net profit for the current period was a loss of ¥6,936,185.15, compared to a profit of ¥58,515.69 in the previous period, indicating a substantial decline[22] - The company reported an operating profit of ¥4,060,739.45, recovering from an operating loss of ¥196,321.84 in the previous period[22] - The basic and diluted earnings per share for the current period were both -0.0021, compared to 0.0009 in the previous period, indicating a negative shift[22] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥2,267,725,919.65, showing a slight decrease of 0.29% from the end of the previous year[5] - The total assets decreased slightly to ¥2,267,725,919.65 from ¥2,274,291,204.20, reflecting a reduction of about 0.3%[20] - Total liabilities decreased to ¥987,734,306.41 from ¥1,002,085,571.44, showing a decline of approximately 1.4%[20] - The total equity attributable to shareholders of the parent company was ¥1,324,547,003.96, down from ¥1,328,376,939.84, a decrease of about 0.3%[20] Cash Flow - The cash flow from operating activities for the year-to-date was -¥18,116,830.21, reflecting a decline of 33.98%[5] - The company’s cash flow from operating activities showed improvement, with a net cash inflow reported[21] - Net cash flow from operating activities was -¥18,116,830.21, an improvement compared to -¥27,440,856.49 in the previous period[23] - Operating cash inflow for the current period reached ¥1,547,423,920.10, an increase from ¥1,369,415,115.54 in the previous period, representing a growth of approximately 13.06%[23] - Cash inflow from investment activities totaled ¥49,248,243.32, slightly down from ¥52,555,354.74 in the previous period[23] - Net cash flow from investment activities increased to ¥38,879,999.99 from ¥35,165,567.54 year-over-year[23] - Cash inflow from financing activities was ¥222,857,000.00, up from ¥213,000,000.00 in the previous period, marking an increase of approximately 8.67%[24] - Net cash flow from financing activities improved to -¥10,635,056.96 from -¥30,736,275.85 in the previous period[24] Shareholder Information - The total number of common shareholders at the end of the reporting period is 31,813[10] - The largest shareholder, Zhang Hangen, holds 28.75% of the shares, totaling 433,423,393 shares[10] - The actual controller, Zhang Hangen, holds 43,342.34 million shares, accounting for 28.75% of the total share capital[16] - The company has not reported any changes in the participation of major shareholders in margin trading and securities lending[11] Other Income and Costs - The company reported a significant increase in investment income, reaching ¥49,158,063.61, a year-on-year increase of 4589.40%[7] - The total operating costs rose to ¥203,450,492.18, an increase of 70.34% year-on-year, driven by higher trade business revenue[7] - The company recorded a substantial increase in other income, totaling ¥1,264,872.02, a decrease of 57.45% compared to the previous year due to reduced government subsidies[7] - Total operating costs increased to ¥294,962,881.08 from ¥226,222,601.90, marking a rise of about 30.4%[21] Inventory and Receivables - Accounts receivable decreased significantly from ¥81,238,491.24 to ¥16,803,709.24, a reduction of about 79.3%[18] - Inventory increased to ¥74,545,626.82 from ¥57,481,221.30, reflecting a rise of approximately 29.8%[18] Equity Transactions - The company completed the transfer of 51% equity in a subsidiary to ADM on May 31, 2021[12] - The company has not disclosed any significant litigation matters in the recent report[13]

证券代码：002496 证券简称：*ST 辉丰 公告编号：2025-037 江苏辉丰生物农业股份有限公司 第九届董事会第十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、董事会会议召开情况 江苏辉丰生物农业股份有限公司（以下简称"公司"）第九届董事会于2025年10月16日 以通讯方式向公司董事发出关于召开公司第九届董事会第十二次会议的通知。本次会议于 2025年10月27日在公司会议室以现场结合通讯方式召开，全体董事9人参加会议，会议由公 司董事长仲汉根先生主持。 1、审议通过《2025年三季度报告》 公司前三季度实现营业收入219,125,723.79元，同比增长42.7%；前三季度归属于上市公 司股东的净利润为-3,227,461.80，同比减少347.45%，归属于上市公司股东的扣除非经常性 损益的净利润-27,491,404.12，同比增长70.62%。 详见同日刊登于《中国证券报》、《证券时报》和巨潮资讯网上的《2025年三季度报告》， 公告编号：2025-038。 表决结果：9票同意，0票反对，0票弃权。 2、审议通过《关于 ...